The US Food and Drug Administration (FDA) remains concerned about the potential of biotin, or vitamin B 7, to interfere with the results of laboratory testing, including troponin testing for diagnosis ...

Biotin can interfere with lab tests, affecting hormone levels and cancer markers, leading to potential misinterpretation of treatment efficacy. Despite its popularity, biotin lacks strong evidence for ...

ANAHEIM, Calif. & CHARLESTON, S.C. & OAKDALE, Minn.--(BUSINESS WIRE)--Veravas, Inc., an emerging diagnostic company, is showcasing for the first time, a newly launched portfolio of laboratory products ...

Company supports FDA recommendation for lab, clinician and patient education about reporting all prescription medication and supplements prior to blood draws. Education on potential interferences in ...

Please provide your email address to receive an email when new articles are posted on . The FDA has updated its safety communication to remind the public, health care providers, lab personnel and lab ...